Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients

NCT00453635 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

88

Enrollment

OTHER

Sponsor class

Stopped Due to poor accrual

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Carboplatin
DRUG: Herceptin
DRUG: Vinorelbine

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]